Jeffrey S. Mathiesen
CIK: 0001296853
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (5 total)
- Apr 3, 2026NMTC
NEUROONE MEDICAL TECHNOLOGIES Corp
Award(A)Direct41.9K shares- - Jul 2, 2025HSDT
HELIUS MEDICAL TECHNOLOGIES, INC.
Award(A)DirectStock Option (Right to Buy)
26.2K shares- - Jun 23, 2025NMTC
NEUROONE MEDICAL TECHNOLOGIES Corp
Award(A)DirectOption to Purchase Common Stock
50K shares- - Feb 14, 2025NMTC
NEUROONE MEDICAL TECHNOLOGIES Corp
Award(A)Direct27.8K shares- - Jan 6, 2025HSDT
HELIUS MEDICAL TECHNOLOGIES, INC.
Award(A)DirectStock Option (Right to Buy)
139.9K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Apr 3, 2026 | NMTC NEUROONE MEDICAL TECHNOLOGIES Corp | Award(A) | 41,929 | - | $0 | Direct |
| Jul 2, 2025 | HSDT HELIUS MEDICAL TECHNOLOGIES, INC. | Award(A) Stock Option (Right to Buy) | 26,200 | - | - | Direct |
| Jun 23, 2025 | NMTC NEUROONE MEDICAL TECHNOLOGIES Corp | Award(A) Option to Purchase Common Stock | 50,000 | - | - | Direct |
| Feb 14, 2025 | NMTC NEUROONE MEDICAL TECHNOLOGIES Corp | Award(A) | 27,778 | - | - | Direct |
| Jan 6, 2025 | HSDT HELIUS MEDICAL TECHNOLOGIES, INC. | Award(A) Stock Option (Right to Buy) | 139,857 | - | - | Direct |
1-5 of 5 transactions
About MATHIESEN JEFFREY S
MATHIESEN JEFFREY S (SEC CIK 0001296853) files insider reports with the SEC as Director of NEUROONE MEDICAL TECHNOLOGIES Corp (NMTC) and CFO and Treasurer of HELIUS MEDICAL TECHNOLOGIES, INC. (HSDT).
Signal8 holds 5 ownership filings by MATHIESEN JEFFREY S, all Form 4s, filed between Jan 8, 2025 and Apr 7, 2026. Those filings report 5 transactions, from Jan 6, 2025 to Apr 3, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on MATHIESEN JEFFREY S's filings is in EDEN PRAIRIE, MN.
Recent filings by MATHIESEN JEFFREY S
- Apr 3, 2026: Grant or award of NMTC shares (Form 4, code A).
- Jul 2, 2025: Grant or award of HSDT derivative securities (Form 4, code A).
- Jun 23, 2025: Grant or award of NMTC derivative securities (Form 4, code A).
- Feb 14, 2025: Grant or award of NMTC shares (Form 4, code A).
- Jan 6, 2025: Grant or award of HSDT derivative securities (Form 4, code A).
Other insiders filing for NEUROONE MEDICAL TECHNOLOGIES Corp (NMTC)
- Wambeke David J., Chief Business Officer
- Johns Emily J., Chief Administrative Officer
- Volker Christopher, Chief Financial Officer
- Christianson Mark, Market Development Director
- Mertens Steve, Chief Technology Officer
- Rosa David A, CEO & President